Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,758
  • Shares Outstanding, K 10,828
  • Annual Sales, $ 440 K
  • Annual Income, $ -35,130 K
  • EBIT $ -69 M
  • EBITDA $ -68 M
  • 60-Month Beta 0.77
  • Price/Sales 120.31
  • Price/Cash Flow N/A
  • Price/Book 0.43

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 63.47%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -1.43
  • Number of Estimates 6
  • High Estimate -1.09
  • Low Estimate -2.02
  • Prior Year -14.07
  • Growth Rate Est. (year over year) +89.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.46 +7.17%
on 06/17/25
5.05 -5.35%
on 07/01/25
+0.07 (+1.49%)
since 06/11/25
3-Month
3.39 +41.00%
on 05/14/25
5.85 -18.29%
on 04/15/25
-0.12 (-2.45%)
since 04/11/25
52-Week
3.39 +41.00%
on 05/14/25
16.00 -70.12%
on 10/28/24
-7.22 (-60.17%)
since 07/11/24

Most Recent Stories

More News
Avalo Therapeutics to Participate in Upcoming Investor Conferences

AVTX : 4.78 (-2.45%)
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors

AVTX : 4.78 (-2.45%)
Avalo Therapeutics to Participate in Upcoming Investor Conferences

AVTX : 4.78 (-2.45%)
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates

AVTX : 4.78 (-2.45%)
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

AVTX : 4.78 (-2.45%)
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

BHVN : 13.93 (-7.32%)
COLL : 32.52 (-1.45%)
TRVI : 6.55 (+2.18%)
AVTX : 4.78 (-2.45%)
Avalo Reports 2024 Financial Results and Recent Business Updates

AVTX : 4.78 (-2.45%)
Avalo Therapeutics to Participate in Upcoming Investor Conferences

AVTX : 4.78 (-2.45%)
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

AVTX : 4.78 (-2.45%)
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer

AVTX : 4.78 (-2.45%)

Business Summary

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is...

See More

Key Turning Points

3rd Resistance Point 5.21
2nd Resistance Point 5.05
1st Resistance Point 4.92
Last Price 4.78
1st Support Level 4.63
2nd Support Level 4.47
3rd Support Level 4.34

See More

52-Week High 16.00
Fibonacci 61.8% 11.18
Fibonacci 50% 9.69
Fibonacci 38.2% 8.21
Last Price 4.78
52-Week Low 3.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar